In silico systems pharmacology to assess drug's therapeutic and toxic effects
Owner/Developer: Current Pharmaceutical Design
| Country: | United States of America |
|---|---|
| Languages: | English |
| Url: | http://www.ncbi.nlm.nih.gov/pubmed/27604605 |
| Description: |
For many years, the "one target, one drug" paradigm has been the driving force behind developments in pharmaceutical research. With the recent advances in molecular biology and genomics technologies, the focus is shifting toward "drug-holistic" systems based approaches (i.e. systems pharmacology). The integration of large and diverse amount of data from chemistry and biology coupled with the development and the application of network-based approaches to cope with these data is the next paradigm of drug discovery. Systems pharmacology offers a novel way of approaching drug discovery by developing models that consider the global physiological environment of protein targets and their modification by drugs. Studying drug action across multiple scales of complexity from molecular and cellular to tissue and organism levels may help identify new druggable disease genes and to design new drugs with a better efficacy and clinical safety. |
| Category: | Publication |
| Channel: | Website |
| Audience: | Researchers - Scientists - Industry |
| User access: | Restricted access |
| Updating frequency: | 2016 |
| Relevance: | Replacement |
| Purpose: | Method development - Documentation and information - Toxicological and safety evaluation |
| Technology/Tools: | Non-testing methods (in silico) |
Did you find what you were looking for?
Yes, I found it! No, I did not!Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.
What are you looking for?
We value your feedback so we can improve the information on the page. Please add your email address if you would like a reply. Thank you in advance for your help.!
Please contact us by email if you have any questions.